PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

For the period ended Dec 31, 2024. Filed Mar 17, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 17, 2025

PACB$2.36+4.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONSOLIDATED BALANCE SHEETS

	December 31,
(in thousands, except per share amounts)	2024	2023
Assets
Current assets
Cash and cash equivalents	$55,370	$179,911
Investments	334,561	451,505
Accounts receivable, net	27,524	36,615
Inventory, net	58,755	56,676
Prepaid expenses and other current assets	18,781	17,040
Short-term restricted cash	690	300
Total current assets	495,681	742,047
Property and equipment, net	30,505	36,432
Operating lease right-of-use assets, net	16,091	32,593
Long-term restricted cash	1,532	2,422
Intangible assets, net	389,572	456,984
Goodwill	317,761	462,261
Other long-term assets	9,305	13,274
Total assets	$1,260,447	$1,746,013
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$16,590	$15,062
Accrued expenses	22,595	45,708
Deferred revenue, current	13,864	16,342
Operating lease liabilities, current	10,026	9,591
Other liabilities, current	3,224	8,326
Total current liabilities	66,299	95,029
Deferred revenue, non-current	5,900	5,530
Contingent consideration liability, non-current	18,700	19,550
Operating lease liabilities, non-current	14,914	31,606
Convertible senior notes, net, non-current	647,494	892,243
Other liabilities, non-current	546	751
Total liabilities	753,853	1,044,709
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.001 par value:
Authorized 50,000 shares; No shares issued or outstanding	—	—
Common stock, $0.001 par value:
Authorized 1,000,000 shares; issued and outstanding 294,418 and 267,744 shares at December 31, 2024 and December 31, 2023, respectively	294	268
Additional paid-in capital	2,654,804	2,539,892
Accumulated other comprehensive income	422	219
Accumulated deficit	(2,148,926)	(1,839,075)
Total stockholders’ equity	506,594	701,304
Total liabilities and stockholders’ equity	$1,260,447	$1,746,013

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.